ReviewAdvanced drug delivery reviews2007
"Alternative" endocytic mechanisms exploited by pathogens: new avenues for therapeutic delivery?
Review in Advanced drug delivery reviews, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Energy-Dependent Endocytosis Is Responsible for Skin Penetration of Formulations Based on a Combination of Indomethacin Nanoparticles and l-Menthol in Rat and Göttingen Minipig.International journal of molecular sciences · 2021Article
- Caveolae as Potential Hijackable Gates in Cell Communication.Frontiers in cell and developmental biology · 2020Review
- Involvement of Endocytosis in the Transdermal Penetration Mechanism of Ketoprofen Nanoparticles.International journal of molecular sciences · 2018Article
- Article
- Cell Penetrating Peptides as Molecular Carriers for Anti-Cancer Agents.Molecules (Basel, Switzerland) · 2018Review
- Cellular uptake of nanoparticles: journey inside the cell.Chemical Society reviews · 2017Review
- A preliminary study on the interaction between Asn-Gly-Arg (NGR)-modified multifunctional nanoparticles and vascular epithelial cells.Acta pharmaceutica Sinica. B · 2017Article
- Internalization of the Active Subunit of theFrontiers in cellular and infection microbiology · 2017Article
- Cellular Endocytosis and Trafficking of Cholera Toxin B-Modified Mesoporous Silica Nanoparticles.Journal of materials chemistry. B · 2016Article
- Non-Viral Nucleic Acid Delivery Strategies to the Central Nervous System.Frontiers in molecular neuroscience · 2016Review
- Autonomous translocation and intracellular trafficking of the cell-penetrating and immune-suppressive effector protein YopM.Cellular and molecular life sciences : CMLS · 2013Article
- Article
- NTS-Polyplex: a potential nanocarrier for neurotrophic therapy of Parkinson's disease.Nanomedicine : nanotechnology, biology, and medicine · 2012Review
- The emergence of multiple particle tracking in intracellular trafficking of nanomedicines.Biophysical reviews · 2012Review
- Action and reaction: the biological response to siRNA and its delivery vehicles.Molecular therapy : the journal of the American Society of Gene Therapy · 2012Review
- Non-degradative intracellular trafficking of highly compacted polymeric DNA nanoparticles.Journal of controlled release : official journal of the Controlled Release Society · 2012Article
- Intracellular trafficking pathways involved in the gene transfer of nano-structured calcium phosphate-DNA particles.Biomaterials · 2011Article
- The utilization of pathogen-like cellular trafficking by single chain block copolymer.Biomaterials · 2010Article
- Differential intra-endothelial delivery of polymer nanocarriers targeted to distinct PECAM-1 epitopes.Journal of controlled release : official journal of the Controlled Release Society · 2008Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
Some pathogens utilize unique routes to enter cells that may evade the intracellular barriers encountered by the typical clathrin-mediated endocytic pathway. Retrograde transport and caveolar uptake are among the better characterized pathways, as alternatives to clathrin-mediated endocytosis, that are known to facilitate entry of pathogens and potential delivery agents. Recent characterization of the trafficking mechanisms of prion proteins and certain bacteria may present new paradigms for strategizing improvements in therapeutic spread and retention of therapy. This review will provide an overview of such endocytic pathways, and discuss current and future possibilities in using these routes as a means to improve therapeutic delivery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.